NYU Langone Medical Center has established a new drug discovery accelerator, the Office of Therapeutics Alliances (OTA). OTA is an innovative, nimble program that advances the discovery of novel therapeutic projects by combining the scientific strengths of NYU Langone investigators in dissecting disease pathways with the expertise of external professional drug discovery and development partners in the biopharma industry.

An international research group, led by Arizona State University professor Qiang "Shawn" Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.

The Findings Pave Way for New Therapies for Treating Pain and Mood Disorders.

Data from a number of in vitro models can be combined to assess the potential for molecules to penetrate the blood-brain barrier (BBB) and cause an effect in the CNS.